Coloplast A/S

Coloplast A/S

World Rank (Aug-2026)
1552
Market Cap (Aug-2026)
15.399 Billion USD
World Rank (Jan-05-2024)
726
Market Cap (Jan-05-2024)
25.359 Billion USD
World Rank (Jul-30-2023)
711
Market Cap (Jul-30-2023)
26.267 Billion USD
World Rank (Jan-07-2022)
601
Market Cap (Jan-07-2022)
34.558 Billion USD
World Rank (Jan-01-2021)
552
Market Cap (Jan-01-2021)
32.457 Billion USD
Headquarters Country
Denmark
Top Healthcare Companies in Europe
Nasdaq / NYSE Code
CLPBY
CEO
Kristian Villumsen
Chairman
Lars Rasmussen
Billionaires
Niels Peter Louis-Hansen
Employee Count
15,022
Employee Count as of Date
As on June-2023
World Region
Europe
World Subregion
Northern Europe
Annual Revenue in USD
4,292 Million USD
Annual Operating Income in USD
1,157 Million USD
Annual Net Income in USD
802 Million USD
Annual Results for Period Ending
For year ending September-2024
Total Assets in USD
7,634 Million USD
Total Liabilities in USD
4,785 Million USD
Total Equity in USD
2,849 Million USD
Balance Sheet for Period Ending
As of September-2024
Business Sector
Healthcare
Medical Equipment / Instruments
HealthCare Products
Company Website
COLOPLAST A/S
Wikipedia
Wikipedia
Yahoo
Yahoo @ Copenhagen
Company Profile

Coloplanst A/S manufactures medical equipment. Coloplast A/S has headquarters is in Denmark.

As of June-2023, they had total 15,022 employees.

Company Products:

  • Ostomy care
  • Continence care
  • Wound care
  • Skin care
  • Interventional Urology
Annual Results Summary

COLOPLAST A/S - Yearly Revenue and Net Income - in Million DKK:

Year - EndingRevenueOperating IncomeNet Income
SEP-202324,5006,8454,783
SEP-202222,5796,9104,706
SEP-202119,4266,3554,825
SEP-202018,5445,8544,197
SEP-201917,9395,5563,873
Balance Sheet Summary

Total Assets as on SEP-2023 was 48,159 Million DKK.

Total Liabilities as on SEP-2023 was 30,860 Million DKK.

Total Equity as on SEP-2023 was 17,299 Million DKK.

Founded Year
1954
Stock Category
S&P EUROPE 350
Stock Exchange
Copenhagen
Nasdaq Nordic

Share